被撤回的出版物: Revamping of Chronic Respiratory Diseases in Low- and Middle-Income Countries (Retracted article. See vol. 11, 2023)

Low- and middle-income countries (LMICs) endure an asymmetrically high burden of worldwide disease and death caused by chronic respiratory diseases (CRDs), i.e., asthma, emphysema, bronchiectasis, and post-tuberculosis lung disease (PTLD). CRDs are firmly related with indigence, infectious diseases, and other non-communicable diseases (NCDs) and add to complex multi-disease with great impact on the lives and livelihood of those affected. The pertinence of CRDs to health and demographic wellbeing is relied upon to increment in the long time ahead, as expectations of life rise and the contending dangers of right on time youth mortality and irresistible infections level. The WHO has distinguished the counteraction and control of NCDs as an earnest improvement issue and crucial for the sustainable development goals (SDSs) by 2030. In this review, we center on CRDs in LMICs. We examine the early life roots of CRDs, challenges in their avoidance, identification and administration in LMICs, and the pathways to resolve for accomplish valid widespread wellbeing inclusion.

Automated summary

Low- and middle-income countries bear a disproportionately high burden of chronic respiratory diseases, which are closely linked to poverty, infectious diseases, and other non-communicable diseases. The prevention and control of NCDs are identified as an urgent development issue by the WHO, crucial for achieving sustainable development goals by 2030. In this context, finding solutions for the prevention, identification, and management of CRDs in LMICs is crucial for achieving universal health coverage.